Skip to main content
. 2022 May 25;77(10):3015–3027. doi: 10.1111/all.15324

TABLE 1.

Demographic characteristics at study entry

Remission/SU

n = 16

Allergic

n = 16

Age (y)
Median (IQR) 5.8 (4.2–8.7) 6.3 (3.8–7.9)
Min–max 2.1–9.5 2.1–10
Weight (kg)
Mean (SD) 23.9 (9.3) 24.6 (10.2)
Male sex
n (%) 12 (75%) 11 (68.8%)
History of doctor diagnosed eczema (ever)
n (%) 12 (75%) 12 (75%)
If ever eczema, medication for eczema in last 12 months
n (% of ever eczema) 9 (75%) 10 (83.3%)
History of doctor‐diagnosed asthma (ever)
n (%) 7 (43.8%) 8 (50%)
If ever asthma, medication for asthma in last 12 months
n (% of asthma ever) 6 (85.7%) 8 (100%)
History of anaphylaxis to peanut*
n (%) 5 (31.2%) 6 (37.5%)
Peanut‐specific SPT wheal size (mm)
Mean (SD) 16.6 (5.4) 17.6 (7.3)
sIgE (kU/L)
Median (IQR) 4.7 (0.9–56.5) 11.7 (2.8–62)

Abbreviations: IQR, interquartile range; SD, standard deviation; kU/L, kilo unit per liter.

*One missing in the placebo group.